Published by Josh White on 10th December 2021
(Sharecast News) - Specialist contract research organisation Open Orphan announced on Friday that its subsidiary hVIVO has signed a $13.4m contract with an unnamed US-based biotechnology company to test its novel antiviral candidate, using the 'hVIVO Influenza Human Challenge' study model.
URL: http://www.digitallook.com/dl/news/story/32325191/...